Pharma Mar SA

ISIN ES0169501022

 | 

WKN A2P9YT

Market cap (in EUR)
1,344 m
Country
Spain
Sector
Healthcare
Dividend yield
1.07%
 

Overview

Description

Pharma Mar SA is a biopharmaceutical holding company, which engages in research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It operates through the following segments: Oncology, Diagnostics, and RNAi. The Oncology segment focuses to the group undertakings whose object is to research, develop, and market anti-tumour drugs. The Diagnostics segment focuses in the development and marketing of diagnostic kits. The RNAi segment develops drugs with therapeutic activity based on reducing or silencing gene expression. The company was founded by José Maria Fernández de Sousa-Faro on April 30, 1986 and is headquartered in Colmenar Viejo, Spain.
Show more Show less
Healthcare Biopharmaceuticals Non-System-Specific Biopharmaceuticals Spain

Financials

Key metrics

Market capitalisation, EUR 1,344 m
EPS, EUR 1.93
P/B ratio 6.6
P/E ratio 38.6
Dividend yield 1.07%

Income statement (2024)

Revenue, EUR 175 m
Net income, EUR 26 m
Profit margin 14.94%

What ETF is Pharma Mar SA in?

There are 5 ETFs which contain Pharma Mar SA. All of these ETFs are listed in the table below. The ETF with the largest weighting of Pharma Mar SA is the L&G Pharma Breakthrough UCITS ETF.
ETF Weight Investment focus Fund size (in m EUR)
Vanguard ESG Developed Europe All Cap UCITS ETF (EUR) Distributing 0.01%
Equity
Europe
Social/Environmental
30
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.00%
Equity
World
Social/Environmental
485
Xtrackers Spanish Equity UCITS ETF 1D 0.19%
Equity
Spain
277
L&G Pharma Breakthrough UCITS ETF 2.75%
Equity
World
Health Care
Innovation
30
Amundi MSCI EMU Small Cap ESG Broad Transition UCITS ETF Dist 0.23%
Equity
Europe
Small Cap
Climate Change
326
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.